AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
10.64
-0.68 (-6.01%)
Apr 28, 2026, 4:00 PM EDT - Market closed
AgomAb Therapeutics NV Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 519 | - | - | - | - | - | |
| Enterprise Value | 383 | - | - | - | - | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | - | |
| Net Debt / Equity Ratio | -0.88 | -0.88 | -0.90 | -0.80 | -1.02 | -1.11 | |
| Net Debt / EBITDA Ratio | 1.95 | 1.95 | 3.54 | 3.89 | 2.99 | - | |
| Net Debt / FCF Ratio | 2.23 | 2.23 | 3.58 | 4.91 | 3.57 | - | |
| Quick Ratio | 6.27 | 6.27 | 19.02 | 12.80 | 2.39 | - | |
| Current Ratio | 6.52 | 6.52 | 19.05 | 12.81 | 2.39 | - | |
| Return on Equity (ROE) | -39.22% | -39.22% | -27.26% | -10.46% | - | -90.33% | |
| Return on Assets (ROA) | -20.58% | -20.58% | -15.90% | -14.32% | - | -49.38% | |
| Return on Capital Employed (ROCE) | -43.90% | -43.90% | -24.30% | -19.40% | -31.80% | -41.30% | |
| Buyback Yield / Dilution | -2064.50% | -2064.50% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.